Walgreens Boots Alliance Inc (NASDAQ:WBA) announced a quarterly dividend on Thursday, July 9th, RTT News reports. Stockholders of record on Wednesday, August 19th will be given a dividend of 0.4675 per share by the pharmacy operator on Friday, September 11th. This represents a $1.87 annualized dividend and a dividend yield of 4.66%. The ex-dividend date of this dividend is Tuesday, August 18th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.46.
Walgreens Boots Alliance has a dividend payout ratio of 33.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Walgreens Boots Alliance to earn $5.92 per share next year, which means the company should continue to be able to cover its $1.83 annual dividend with an expected future payout ratio of 30.9%.
NASDAQ:WBA opened at $40.12 on Friday. The company has a debt-to-equity ratio of 1.34, a current ratio of 0.66 and a quick ratio of 0.32. The firm has a market cap of $37.10 billion, a price-to-earnings ratio of 10.29, a price-to-earnings-growth ratio of 2.50 and a beta of 0.55. The firm’s fifty day moving average price is $42.35 and its 200 day moving average price is $47.13. Walgreens Boots Alliance has a 1-year low of $36.65 and a 1-year high of $64.50.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, July 9th. The pharmacy operator reported $0.83 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.10 by ($0.27). Walgreens Boots Alliance had a net margin of 2.52% and a return on equity of 21.26%. The firm had revenue of $34.63 billion during the quarter, compared to analysts’ expectations of $34.32 billion. During the same period in the previous year, the firm earned $1.47 EPS. The firm’s revenue was up .1% on a year-over-year basis. As a group, analysts expect that Walgreens Boots Alliance will post 5.36 earnings per share for the current fiscal year.
Several equities analysts recently issued reports on WBA shares. Citigroup reduced their price objective on Walgreens Boots Alliance from $48.00 to $43.00 and set a “neutral” rating for the company in a report on Friday. Deutsche Bank lowered their price objective on shares of Walgreens Boots Alliance from $43.00 to $38.00 and set a “hold” rating on the stock in a research note on Friday. Mizuho cut their target price on shares of Walgreens Boots Alliance from $53.00 to $48.00 and set a “neutral” rating for the company in a research report on Thursday, June 4th. Bank of America reduced their price target on shares of Walgreens Boots Alliance from $43.00 to $40.00 and set an “underperform” rating on the stock in a report on Friday. Finally, Cowen dropped their price objective on shares of Walgreens Boots Alliance from $54.00 to $48.00 and set a “market perform” rating for the company in a research note on Tuesday, May 19th. Three analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $46.64.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
See Also: What are Institutional Investors?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.